The Recall Desk

Manufacturer

Animas Corporation

6 recalls in our database name Animas Corporation as the manufacturing or recalling firm.

What the numbers show

Total
6
Critical
0
Severe
1
Most recent
2015-02-11

Of the 6 recalls from Animas Corporation we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1 (17%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–6 of 6

  • SevereFDA (Devices)·Z-1034-2015·2015-02-11

    Animas Vibe Insulin Pump Recalled Due to Calibration Factor Overwrite

    Animas Corporation is recalling 1,235 Vibe Insulin Infusion Pumps because calibration factors were overwritten, potentially causing the pump to fail to detect cartridges or alarms.

    Product
    Animas Vibe Insulin Infusion Pump. This product is indicated for continuous subcutaneous infusion of insulin for the treatment of diabetes and has a continuous glucose monitoring feature.
    Category
    Medical Device
    Distribution
    0 states
  • ModerateFDA (Devices)·Z-0137-2015·2014-11-05

    Animas Vibe Insulin Infusion Pump Recalled for Keypad Wear Issues

    Animas Corporation is recalling 1,938 Vibe Insulin Infusion Pumps because keypad wear over time contributes to damage. The recall covers units distributed in France, Italy, Sweden, and the UK.

    Product
    Animas Vibe Insulin Infusion Pump and System. These products are indicated for continuous subcutaneous infusion of insulin for the treatment of insulin-requiring diabetes.
    Category
    Medical Device
    Distribution
    0 states
  • ModerateFDA (Devices)·Z-0136-2015·2014-11-05

    Animas Vibe Insulin Pump Recalled for Incorrect Hebrew Translation

    Animas Corporation is recalling 1,028 Vibe Insulin Infusion Pumps in Israel due to incorrect Hebrew language translations and omitted text on the display screen.

    Product
    Animas Vibe Insulin Infusion Pump. This product is indicated for continuous subcutaneous infusion of insulin for the treatment of diabetes and has a continuous glucose monitoring feature.
    Category
    Medical Device
    Distribution
    0 states
  • ModerateFDA (Devices)·Z-0993-2013·2013-04-10

    Animas 2020 Insulin Pump Recall for False Alarm Component Issue

    Animas Corporation is recalling 7,157 Animas 2020 insulin pumps due to a component issue that may cause false alarms for loss of prime, occlusion, or no cartridge detected.

    Product
    Animas(R) 2020 Insulin Infusion Pump Product Usage: This product is indicated for continuous subcutaneous infusion of insulin for the treatment of insulin-requiring diabetes.
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-0836-2013·2013-02-27

    Animas Insulin Pumps Cease Operation Due to Calendar Date Limit

    Animas Corporation is recalling insulin infusion pumps that will stop operating on January 1, 2016, due to an internal calendar date limit.

    Product
    Animas(R) 2020, Animas(R) IR 1250 (1200 plus), Animas(R) IR 1200 Insulin Infusion Pumps Indicated for continuous subcutaneous infusion of insulin.
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • ModerateFDA (Devices)·Z-0005-2013·2012-10-10

    Animas Insulin Pumps Recalled for Keypad Wear and Peeling

    Animas Corporation is recalling insulin pumps due to keypad wear that may cause tearing or peeling. The recall covers 236,470 units distributed worldwide.

    Product
    IR1200, IR1250(IR1200 Plus), 2020 and One Touch(R) Ping(R) Insulin Pump glucose management system. The device is intended to deliver insulin therapy.
    Category
    Medical Device
    Distribution
    Distributed nationwide